-
Science & technology
Science & technology
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
- Overview
- Our pipeline
- Matrix-M™ adjuvant
- Recombinant, protein-based nanoparticle vaccine
- Global vaccine approval/authorization map
COVID-19 UPDATESNovavax has demonstrated its ability to quickly produce viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Who we are
Who we are
We are a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
Insights
Insights
Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.
SARS investigational vaccine
Paused developmental vaccine candidates
Therapeutic area | Infectious disease | Status | Technology |
---|---|---|---|
Respiratory diseases | Severe Acute Respiratory Syndrome (SARS) | Preclinical |
Therapeutic area
Respiratory diseases
Infectious disease
Severe Acute Respiratory Syndrome (SARS)
Status
Preclinical
Technology
About the candidate
Our Severe Acute Respiratory Syndrome (SARS) investigational vaccine is a coronavirus spike protein nanoparticle that works in concert with our Matrix-M™ adjuvant.
Why it matters
While COVID-19 is the most pressing global threat today, less common coronaviruses also take a toll on global populations. These include MERS, which has a fatality rate of 35% and has been reported in 27 countries since 2012,1 and SARS, which has a low fatality rate but is highly transmissible.2 These coronaviruses also demand effective vaccines to help prevent future outbreaks.
- Middle Eastern Respiratory Syndrome. WHO. Available at: https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers#tab=tab_1 [Accessed 3 Sept 2021].
- Severe Acute Respiratory Syndrome (SARS). WHO. Available at: https://www.who.int/health-topics/severe-acute-respiratory-syndrome#tab=tab_1 [Accessed 3 Sept 2021].